Finance

Lists
688799:SHA
Hunan Warrant Pharmaceutical Co Ltd
CNÂ¥49.61
+0.96%
(+0.47) 1D
Sep 8, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688799...
Open
CNÂ¥49.39
High
CNÂ¥49.84
Low
CNÂ¥48.51
Mkt. cap
6.68B
Avg. vol.
3.00M
Volume
1.08M
Dividend
0.36%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 1, 2026
P/E ratio
28.15
52-wk high
CNÂ¥66.88
52-wk low
CNÂ¥40.33
EPS
CNÂ¥1.76
No. of employees
1K
Open
CNÂ¥49.39
High
CNÂ¥49.84
Low
CNÂ¥48.51
Mkt. cap
6.68B
Avg. vol.
3.00M
Volume
1.08M
Dividend
0.36%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 1, 2026
P/E ratio
28.15
52-wk high
CNÂ¥66.88
52-wk low
CNÂ¥40.33
EPS
CNÂ¥1.76
No. of employees
1K
About Hunan Warrant Pharmaceutical Co Ltd
CEO-
Employees1.29K
FoundedApr 30, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
372.11M
418.41M
324.55M
336.15M
Cost of goods sold
146.21M
171.71M
138.64M
148.63M
Cost of revenue
146.21M
171.71M
138.64M
148.63M
Research and development expenses
21.39M
33.80M
21.01M
32.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151.42M
176.85M
128.44M
113.95M
Operating expense
162.18M
217.76M
148.00M
143.01M
Total operating expenses
308.40M
389.47M
286.64M
291.64M
Operating income
63.71M
28.93M
37.90M
44.51M
Other non operating income
-1.89M
2.06M
-667.11K
-9.30M
EBT including unusual items
140.61M
25.06M
33.19M
41.39M
EBT excluding unusual items
151.81M
19.87M
37.75M
37.89M
Income tax expense
5.78M
-6.09M
6.31M
3.67M
Effective tax rate
4.11%
-24.30%
19.02%
8.86%
Other operating expenses
-10.17M
6.34M
700.93K
-5.84M
Net income
136.01M
31.16M
26.88M
37.72M
Net profit margin
36.55%
7.45%
8.28%
11.22%
Earnings per share
-
-
-
-
Interest and investment income
89.80M
-
1.68M
2.69M
Interest expense
-
-10.14M
-1.17M
-
Net interest expenses
89.80M
-10.14M
517.17K
2.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
80.94M
46.70M
55.67M
64.76M
Gain or loss from assets sale
-
413.00
-
-
AI content may include mistakes. Learn more
Google apps